A study by Mathew and colleagues found 3 distinct immunotypes in hospitalized COVID-19 patients: (1) robust activation of CD4+ T cells and highly activated or exhausted CD8+ T cells, (2) less robust CD4+ T cells and highly functional effector-like CD8+ T cell responses, and (3) a lack of lymphocyte response (93). This evidence concerns the gene CD4 and COVID-19.